Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Free light chains injure proximal tubule cells through the STAT1/HMGB1/TLR axis
Rohit Upadhyay, Wei-Zhong Ying, Zannatul Nasrin, Hana Safah, Edgar A. Jaimes, Wenguang Feng, Paul W. Sanders, Vecihi Batuman
Rohit Upadhyay, Wei-Zhong Ying, Zannatul Nasrin, Hana Safah, Edgar A. Jaimes, Wenguang Feng, Paul W. Sanders, Vecihi Batuman
View: Text | PDF
Research Article Cell biology Nephrology

Free light chains injure proximal tubule cells through the STAT1/HMGB1/TLR axis

  • Text
  • PDF
Abstract

Free light chains (FLCs) induce inflammatory pathways in proximal tubule cells (PTCs). The role of TLRs in these responses is unknown. Here we present findings on the role of TLRs in FLC-induced PTC injury. We exposed human kidney PTC cultures to κ and λ FLCs and used cell supernatants and pellets for ELISA and gene expression studies. We also analyzed tissues from Stat1–/– and littermate control mice treated with daily i.p. injections of a κ FLC for 10 days. FLCs increased the expression of TLR2, TLR4, and TLR6 via HMGB1, a damage-associated molecular pattern. Countering TLR2, TLR4, and TLR6 through GIT-27 or specific TLR siRNAs reduced downstream cytokine responses. Blocking HMGB1 through siRNA or pharmacologic inhibition, or via STAT1 inhibition, reduced FLC-induced TLR2, TLR4, and TLR6 expression. Blocking endocytosis of FLCs through silencing of megalin/cubilin, with bafilomycin A1 or hypertonic sucrose, attenuated FLC-induced cytokine responses in PTCs. IHC showed decreased TLR4 and TLR6 expression in kidney sections from Stat1–/– mice compared with their littermate controls. PTCs exposed to FLCs released HMGB1, which induced expression of TLR2, TLR4, and TLR6 and downstream inflammation. Blocking FLCs’ endocytosis, Stat1 knockdown, HMGB1 inhibition, and TLR knockdown each rescued PTCs from FLC-induced injury.

Authors

Rohit Upadhyay, Wei-Zhong Ying, Zannatul Nasrin, Hana Safah, Edgar A. Jaimes, Wenguang Feng, Paul W. Sanders, Vecihi Batuman

×

Figure 5

FLCs induced HMGB1 release and TLR2/TLR 4/TLR6 expression in vivo, which was mitigated in STAT1–/– mice.

Options: View larger image (or click on image) Download as PowerPoint
FLCs induced HMGB1 release and TLR2/TLR 4/TLR6 expression in vivo, which...
(A) Six different FLCs (n = 8 samples in each group) increased the release of HMGB1 compared with vehicle-treated cells and cells incubated in medium containing BSA, 5 mg/ml (*P < 0.0001). Data were analyzed using 1-way ANOVA. (B) Treatment with siRNA reduced STAT1 protein levels by about 70%–75%; no effect of the nontargeting siRNA on STAT1 was observed. (C) Knockdown of STAT1 inhibited FLC-induced increases in HMGB1 (n = 12 samples in each group) by HK-2 cells. Concentration of HMGB1 in medium was divided by total protein of cellular lysates in each sample. Data were analyzed using 2-way ANOVA. The analysis comparing the main effects of the FLC and the interaction effect between the FLC and siRNA on HMGB1 showed the main effect for FLC yielded an F ratio of F(2, 66) = 228.1, P < 0.0001, and the effect of siRNA yielded an F ratio of F(1, 66) = 654.3, P < 0.0001. The interaction effect was significant: F ratio of F(2, 66) = 133.2, P < 0.0001. *P < 0.0001. (D) FLCs induced TLR2, TLR4, and TLR6 gene expression significantly in WT mice but not in Stat1–/– mice. (E and F) Representative IHC slides from WT and Stat1–/– mice. The WT mice treated with FLCs showed positive staining for TLR4 (E, left) and TLR6 (F, left); Stat1–/– kidneys were negative or weakly positive (E and F, left). A-κ2- d1 and d2 denote different doses of FLCs injected to mice. Lower dose (termed κ2-d1 = 0.033 mg/g BW) or higher dose (termed κ2-d2 = 0.165 mg/g BW) of κ2 FLC in PBS. Untreated controls were negative. FLCs, free light chains.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts